Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3762816017 | Betamethasone (as betamethasone dipropionate) 500 nanogram/mg cutaneous ointment | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3762817014 | Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Is a | Product containing betamethasone in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Betamethasone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Adrenal hormone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Corticosterone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Conventional release cutaneous ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Is a | Product containing only betamethasone in cutaneous dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | nanogram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has precise active ingredient | Betamethasone dipropionate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has basis of strength substance | Betamethasone | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Betamethasone dipropionate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Betamethasone 0.05% ointment - product | Is a | False | Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Diprosone 0.05% ointment (Organon Pharma (UK) Ltd) | Is a | False | Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Betamethasone dipropionate 0.05% ointment 100 gram | Is pack of | False | Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Betamethasone dipropionate 0.05% ointment 30 gram | Is pack of | False | Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR